A National Research Priority Program of  
the

Logo der Deutschen Forschungsgesellschaft

Pressemitteilung Uniklinik Köln, März 2012

Höhere Anfälligkeit für Schizophrenie bei Rauchern

Rauchen verändert die Wirkung eines Schizophrenie-Risikogens.
Wissenschaftler der Uniklinik Köln und der Universität Zürich
zeigen: Gesunde Menschen, die dieses Risikogen tragen und
rauchen, verarbeiten akustische Reize ähnlich schlecht wie
Patienten mit einer Schizophrenie. Dabei ist der Effekt umso stärker,
je mehr die Betroffenen rauchen.

read more..

 

 

 

 

Projects

P10 Impact of the nicotinergic alpha7 receptor on cortical plasticity in smokers and non-smokers

Funding Period 2011 - 2013

P10

Impact of the nicotinergic alpha7 receptor on cortical plasticity in smokers and non-smokers (NI 683/4-2)


PD Dr. med. Michael Nitsche (Principle Investigator)
University of Goettingen
Dept. of Clinical Neurophysiology
Robert-Koch-Strasse 40

37075 Goettingen

+49-551-39-12631
mnitsch1(at)gwdg.de

Together with:

 

Prof. Dr. Walter Paulus
University of Goettingen
Dept. of Clinical Neurophysiology
Robert-Koch-Strasse 40

37075 Goettingen
+49-(0)551/39-6650

wpaulus(at)med.uni-goettingen.de

Dr. Jessica Grundey

University of Goettingen
Dept. of Clinical Neurophysiology
Robert-Koch-Strasse 40

37075 Goettingen

+49 551 39-8457

Jgrundey(at)med.uni-goettingen.de

 

 

Nicotine is a strong inductor and modulator of cortical activity and long-term potentiation. Hereby it influences learning and memory processes as well as addiction. Nicotine-dependent cognitive improvements in humans seem to differ between smoking and not smoking individuals, as presumed by the "deficit compensating hypothesis" of nicotine consumption. This project pursues the following aims: (i) First we will differentiate acute cortical excitability shifts elicited by nicotine in smokers and non-smokers (Collaboration with Prof. Wodarz). (ii) We will induce LTPand LTD-like cortical neuroplasticity changes by transcranial direct current stimulation with and without nicotine in smokers and non-smokers, (iii) We will correlate nicotineenhanced neuroplasticity with cognitive performance and performance-related cerebral activity, as revealed by fMRI, in smokers and non-smokers, (iv) The interdependence of neurophysiological and cognitive effects with genetically defined phenotypes (collaboration with Prof. Winterer) of smokers will be explored. In summary, we aim to develop a neurophysiology-based in vivo model of the impact of nicotine on cerebral function, which will help to understand the mechanisms of nicotine addiction and relapse after withdrawal to a greater extent.


© Cologne Center for Genomics 2012 webdesign: blickpunkt |x|